The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bacille Calmette-Guerin Vaccine Market Research Report 2025
Synopsis
Bacille Calmette-Guerin Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys.
The global Bacille Calmette-Guerin Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bacille Calmette-Guerin Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bacille Calmette-Guerin Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bacille Calmette-Guerin Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bacille Calmette-Guerin Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacille Calmette-Guerin Vaccine.
Report Scope
The Bacille Calmette-Guerin Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bacille Calmette-Guerin Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacille Calmette-Guerin Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Segment by Type
Immune
Therapy
Segment by Application
Private Distribution Channel
Public Distribution Channel
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacille Calmette-Guerin Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacille Calmette-Guerin Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Bacille Calmette-Guerin Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys.
The global Bacille Calmette-Guerin Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bacille Calmette-Guerin Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bacille Calmette-Guerin Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bacille Calmette-Guerin Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bacille Calmette-Guerin Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacille Calmette-Guerin Vaccine.
Report Scope
The Bacille Calmette-Guerin Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bacille Calmette-Guerin Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacille Calmette-Guerin Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Segment by Type
Immune
Therapy
Segment by Application
Private Distribution Channel
Public Distribution Channel
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacille Calmette-Guerin Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacille Calmette-Guerin Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bacille Calmette-Guerin Vaccine Market Overview
1.1 Product Overview and Scope of Bacille Calmette-Guerin Vaccine
1.2 Bacille Calmette-Guerin Vaccine Segment by Type
1.2.1 Global Bacille Calmette-Guerin Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Immune
1.2.3 Therapy
1.3 Bacille Calmette-Guerin Vaccine Segment by Application
1.3.1 Global Bacille Calmette-Guerin Vaccine Market Value by Application: (2024-2030)
1.3.2 Private Distribution Channel
1.3.3 Public Distribution Channel
1.4 Global Bacille Calmette-Guerin Vaccine Market Size Estimates and Forecasts
1.4.1 Global Bacille Calmette-Guerin Vaccine Revenue 2019-2030
1.4.2 Global Bacille Calmette-Guerin Vaccine Sales 2019-2030
1.4.3 Global Bacille Calmette-Guerin Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bacille Calmette-Guerin Vaccine Market Competition by Manufacturers
2.1 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bacille Calmette-Guerin Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Bacille Calmette-Guerin Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Product Type & Application
2.7 Bacille Calmette-Guerin Vaccine Market Competitive Situation and Trends
2.7.1 Bacille Calmette-Guerin Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bacille Calmette-Guerin Vaccine Players Market Share by Revenue
2.7.3 Global Bacille Calmette-Guerin Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bacille Calmette-Guerin Vaccine Retrospective Market Scenario by Region
3.1 Global Bacille Calmette-Guerin Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bacille Calmette-Guerin Vaccine Global Bacille Calmette-Guerin Vaccine Sales by Region: 2019-2030
3.2.1 Global Bacille Calmette-Guerin Vaccine Sales by Region: 2019-2024
3.2.2 Global Bacille Calmette-Guerin Vaccine Sales by Region: 2025-2030
3.3 Global Bacille Calmette-Guerin Vaccine Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2019-2030
3.3.1 Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2019-2024
3.3.2 Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2025-2030
3.4 North America Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.4.1 North America Bacille Calmette-Guerin Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bacille Calmette-Guerin Vaccine Sales by Country (2019-2030)
3.4.3 North America Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.5.1 Europe Bacille Calmette-Guerin Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bacille Calmette-Guerin Vaccine Sales by Country (2019-2030)
3.5.3 Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Bacille Calmette-Guerin Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bacille Calmette-Guerin Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.7.1 Latin America Bacille Calmette-Guerin Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bacille Calmette-Guerin Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacille Calmette-Guerin Vaccine Sales by Type (2019-2030)
4.1.1 Global Bacille Calmette-Guerin Vaccine Sales by Type (2019-2024)
4.1.2 Global Bacille Calmette-Guerin Vaccine Sales by Type (2025-2030)
4.1.3 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2019-2030)
4.2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2019-2024)
4.2.2 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2025-2030)
4.2.3 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Bacille Calmette-Guerin Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bacille Calmette-Guerin Vaccine Sales by Application (2019-2030)
5.1.1 Global Bacille Calmette-Guerin Vaccine Sales by Application (2019-2024)
5.1.2 Global Bacille Calmette-Guerin Vaccine Sales by Application (2025-2030)
5.1.3 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2019-2030)
5.2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2019-2024)
5.2.2 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2025-2030)
5.2.3 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Bacille Calmette-Guerin Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Bacille Calmette-Guerin Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 China National Biotec
6.4.1 China National Biotec Corporation Information
6.4.2 China National Biotec Description and Business Overview
6.4.3 China National Biotec Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China National Biotec Bacille Calmette-Guerin Vaccine Product Portfolio
6.4.5 China National Biotec Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute of India Bacille Calmette-Guerin Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Intervax
6.6.1 Intervax Corporation Information
6.6.2 Intervax Description and Business Overview
6.6.3 Intervax Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Intervax Bacille Calmette-Guerin Vaccine Product Portfolio
6.6.5 Intervax Recent Developments/Updates
6.7 GSBPL
6.6.1 GSBPL Corporation Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSBPL Bacille Calmette-Guerin Vaccine Product Portfolio
6.7.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacille Calmette-Guerin Vaccine Industry Chain Analysis
7.2 Bacille Calmette-Guerin Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacille Calmette-Guerin Vaccine Production Mode & Process
7.4 Bacille Calmette-Guerin Vaccine Sales and Marketing
7.4.1 Bacille Calmette-Guerin Vaccine Sales Channels
7.4.2 Bacille Calmette-Guerin Vaccine Distributors
7.5 Bacille Calmette-Guerin Vaccine Customers
8 Bacille Calmette-Guerin Vaccine Market Dynamics
8.1 Bacille Calmette-Guerin Vaccine Industry Trends
8.2 Bacille Calmette-Guerin Vaccine Market Drivers
8.3 Bacille Calmette-Guerin Vaccine Market Challenges
8.4 Bacille Calmette-Guerin Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Bacille Calmette-Guerin Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bacille Calmette-Guerin Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Bacille Calmette-Guerin Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bacille Calmette-Guerin Vaccine Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bacille Calmette-Guerin Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bacille Calmette-Guerin Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bacille Calmette-Guerin Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bacille Calmette-Guerin Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacille Calmette-Guerin Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bacille Calmette-Guerin Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bacille Calmette-Guerin Vaccine Sales by Region (2019-2024) & (Units)
Table 18. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Bacille Calmette-Guerin Vaccine Sales by Region (2025-2030) & (Units)
Table 20. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Bacille Calmette-Guerin Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Bacille Calmette-Guerin Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Bacille Calmette-Guerin Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bacille Calmette-Guerin Vaccine Sales by Country (2019-2024) & (Units)
Table 27. North America Bacille Calmette-Guerin Vaccine Sales by Country (2025-2030) & (Units)
Table 28. North America Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bacille Calmette-Guerin Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bacille Calmette-Guerin Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bacille Calmette-Guerin Vaccine Sales by Country (2019-2024) & (Units)
Table 32. Europe Bacille Calmette-Guerin Vaccine Sales by Country (2025-2030) & (Units)
Table 33. Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bacille Calmette-Guerin Vaccine Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Bacille Calmette-Guerin Vaccine Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bacille Calmette-Guerin Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bacille Calmette-Guerin Vaccine Sales by Country (2019-2024) & (Units)
Table 42. Latin America Bacille Calmette-Guerin Vaccine Sales by Country (2025-2030) & (Units)
Table 43. Latin America Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bacille Calmette-Guerin Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Country (2019-2024) & (Units)
Table 47. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Country (2025-2030) & (Units)
Table 48. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bacille Calmette-Guerin Vaccine Sales (Units) by Type (2019-2024)
Table 51. Global Bacille Calmette-Guerin Vaccine Sales (Units) by Type (2025-2030)
Table 52. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Bacille Calmette-Guerin Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Bacille Calmette-Guerin Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Bacille Calmette-Guerin Vaccine Sales (Units) by Application (2019-2024)
Table 61. Global Bacille Calmette-Guerin Vaccine Sales (Units) by Application (2025-2030)
Table 62. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Bacille Calmette-Guerin Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Bacille Calmette-Guerin Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Bacille Calmette-Guerin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck Bacille Calmette-Guerin Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Bacille Calmette-Guerin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Pasteur Bacille Calmette-Guerin Vaccine Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. Japan BCG Lab Corporation Information
Table 81. Japan BCG Lab Description and Business Overview
Table 82. Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Japan BCG Lab Bacille Calmette-Guerin Vaccine Product
Table 84. Japan BCG Lab Recent Developments/Updates
Table 85. China National Biotec Corporation Information
Table 86. China National Biotec Description and Business Overview
Table 87. China National Biotec Bacille Calmette-Guerin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. China National Biotec Bacille Calmette-Guerin Vaccine Product
Table 89. China National Biotec Recent Developments/Updates
Table 90. Serum Institute of India Corporation Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India Bacille Calmette-Guerin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Serum Institute of India Bacille Calmette-Guerin Vaccine Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. Intervax Corporation Information
Table 96. Intervax Description and Business Overview
Table 97. Intervax Bacille Calmette-Guerin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Intervax Bacille Calmette-Guerin Vaccine Product
Table 99. Intervax Recent Developments/Updates
Table 100. GSBPL Corporation Information
Table 101. GSBPL Description and Business Overview
Table 102. GSBPL Bacille Calmette-Guerin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. GSBPL Bacille Calmette-Guerin Vaccine Product
Table 104. GSBPL Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Bacille Calmette-Guerin Vaccine Distributors List
Table 108. Bacille Calmette-Guerin Vaccine Customers List
Table 109. Bacille Calmette-Guerin Vaccine Market Trends
Table 110. Bacille Calmette-Guerin Vaccine Market Drivers
Table 111. Bacille Calmette-Guerin Vaccine Market Challenges
Table 112. Bacille Calmette-Guerin Vaccine Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bacille Calmette-Guerin Vaccine
Figure 2. Global Bacille Calmette-Guerin Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bacille Calmette-Guerin Vaccine Market Share by Type in 2023 & 2030
Figure 4. Immune Product Picture
Figure 5. Therapy Product Picture
Figure 6. Global Bacille Calmette-Guerin Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Bacille Calmette-Guerin Vaccine Market Share by Application in 2023 & 2030
Figure 8. Private Distribution Channel
Figure 9. Public Distribution Channel
Figure 10. Global Bacille Calmette-Guerin Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Bacille Calmette-Guerin Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Bacille Calmette-Guerin Vaccine Sales (2019-2030) & (Units)
Figure 13. Global Bacille Calmette-Guerin Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 14. Bacille Calmette-Guerin Vaccine Report Years Considered
Figure 15. Bacille Calmette-Guerin Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Bacille Calmette-Guerin Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Bacille Calmette-Guerin Vaccine Players: Market Share by Revenue in 2023
Figure 18. Bacille Calmette-Guerin Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Bacille Calmette-Guerin Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2019-2030)
Figure 43. Latin America Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Bacille Calmette-Guerin Vaccine by Type (2019-2030)
Figure 53. Global Revenue Market Share of Bacille Calmette-Guerin Vaccine by Type (2019-2030)
Figure 54. Global Bacille Calmette-Guerin Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Bacille Calmette-Guerin Vaccine by Application (2019-2030)
Figure 56. Global Revenue Market Share of Bacille Calmette-Guerin Vaccine by Application (2019-2030)
Figure 57. Global Bacille Calmette-Guerin Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 58. Bacille Calmette-Guerin Vaccine Value Chain
Figure 59. Bacille Calmette-Guerin Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
